Executive dysfunction in drug-resistant epilepsy is common and linked to greater ASM load/number of ASMs and increased ...

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Ovid Therapeutics (OVID) shares jumped over 40% premarket as the biopharmaceutical company reported favorable safety and tolerability results for the 7 mg dose of its OV329 epilepsy drug, while ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Bright Minds Biosciences Inc (NASDAQ:DRUG) is among the best psychedelic stocks to buy in 2026. The company has multiple ...

An old epilepsy drug for sleep apnoea has sharply reduced night‑time breathing pauses in a major European trial. Could ...

Ovid Therapeutics Inc. (NASDAQ:OVID) said Wednesday it has raised $60 million through a private placement to support the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Neuromodulation offers personalized, responsive ...

Share on Pinterest A new drug reduced seizures in subjects with treatment resistant epilepsy in a recent clinical trial. The Good Brigade/Getty Images Researchers say a new medication may potentially ...

Epileptic seizures alter sleep by prolonging the stage that's central to memory formation, potentially predisposing the brain to "remember" how to trigger subsequent seizures more easily, a small ...